Trials / Completed
CompletedNCT02055274
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Luye Pharma Group Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the pharmacokinetics (PK) of LY03003 following multiple escalating intramuscular injections, as compared to Neupro patch and to evaluate the safety and tolerability and preliminary efficacy of multiple ascending dose (MAD) of LY03003 following intramuscular injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY03003 | |
| DRUG | Neupro |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2014-02-05
- Last updated
- 2015-10-21
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02055274. Inclusion in this directory is not an endorsement.